Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Add-On Ramelteon in Bipolar I Disorder With Clinically Significant Sleep Disturbance

This study has been terminated.
(sponsor terminated study)
Sponsor:
Collaborators:
Takeda
University of Cincinnati
Information provided by (Responsible Party):
Lindner Center of HOPE
ClinicalTrials.gov Identifier:
NCT00585208
First received: December 20, 2007
Last updated: May 8, 2013
Last verified: May 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2010
  Primary Completion Date: September 2010 (Final data collection date for primary outcome measure)
Publications: